ACP
VERV

Acuta Capital Partners’s Verve Therapeutics VERV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-162,724
Closed -$744K 36
2025
Q1
$744K Buy
162,724
+2,524
+2% +$11.5K 0.86% 28
2024
Q4
$904K Buy
160,200
+14,100
+10% +$79.5K 0.91% 28
2024
Q3
$707K Buy
+146,100
New +$707K 0.57% 29